User profiles for Melissa Brouwers
Melissa BrouwersUniversity of Ottawa Verified email at uottawa.ca Cited by 22784 |
[HTML][HTML] AGREE II: advancing guideline development, reporting and evaluation in health care
• The instrument successfully differentiates between highand low-quality guideline content. 7•
The new user’s manual is well received by users. 7• Users provided considerable …
The new user’s manual is well received by users. 7• Users provided considerable …
[HTML][HTML] How can we improve guideline use? A conceptual framework of implementability
AR Gagliardi, MC Brouwers, VA Palda… - Implementation …, 2011 - Springer
Background Guidelines continue to be underutilized, and a variety of strategies to improve
their use have been suboptimal. Modifying guideline features represents an alternative, but …
their use have been suboptimal. Modifying guideline features represents an alternative, but …
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer
…, P McAllister, E Van Cutsem, M Brouwers… - Journal of clinical …, 2004 - ascopubs.org
Purpose To address whether all medically fit patients with curatively resected stage II colon
cancer should be offered adjuvant chemotherapy as part of routine clinical practice, to …
cancer should be offered adjuvant chemotherapy as part of routine clinical practice, to …
[HTML][HTML] The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines
MC Brouwers, K Kerkvliet, K Spithoff… - Bmj, 2016 - bmj.com
AGREE II is a widely used standard for assessing the methodological quality of practice
guidelines. This article describes the development of the AGREE Reporting Checklist, which …
guidelines. This article describes the development of the AGREE Reporting Checklist, which …
Development of the AGREE II, part 2: assessment of validity of items and tools to support application
Background: We established a program of research to improve the development, reporting
and evaluation of practice guidelines. We assessed the construct validity of the items and user…
and evaluation of practice guidelines. We assessed the construct validity of the items and user…
Development of the AGREE II, part 1: performance, usefulness and areas for improvement
Background: We undertook research to improve the AGREE instrument, a tool used to evaluate
guidelines. We tested a new seven-point scale, evaluated the usefulness of the original …
guidelines. We tested a new seven-point scale, evaluated the usefulness of the original …
Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review
J Huang, L Barbera, M Brouwers… - Journal of clinical …, 2003 - ascopubs.org
Purpose: The objective of this study was to synthesize what is known about the relationship
between delay in radiotherapy (RT) and the outcomes of RT. Methods: A systematic review …
between delay in radiotherapy (RT) and the outcomes of RT. Methods: A systematic review …
A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer
…, K Thephamongkhol, M Brouwers… - The Journal of …, 2004 - academic.oup.com
Radioactive iodine remnant ablation destroys residual thyroid tissue after surgical resection
of papillary or follicular thyroid cancer. We systematically reviewed 1543 English references …
of papillary or follicular thyroid cancer. We systematically reviewed 1543 English references …
Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site …
…, ML Charette, J Maroun, MC Brouwers… - Journal of clinical …, 2004 - ascopubs.org
Purpose To develop a systematic review that would address the following question: Should
patients with stage II colon cancer receive adjuvant therapy? Methods A systematic review …
patients with stage II colon cancer receive adjuvant therapy? Methods A systematic review …
[PDF][PDF] Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non–small …
…, CE Desch, MR Somerfield, MC Brouwers… - Journal of clinical …, 2007 - academia.edu
… Brouwers, Gail Darling, Peter M. Ellis, Laurie E. Gaspar, Harvey I. … Brouwers, Gail
Darling, Peter M. Ellis, Harvey I. Pass, David R. … Brouwers …
Darling, Peter M. Ellis, Harvey I. Pass, David R. … Brouwers …